Total Payments
$11,331
2024 Payments
$1,862
Companies
27
Transactions
509
Medicare Patients
790
Medicare Billing
$186,672
Payment Breakdown by Category
Food & Beverage$11,289 (99.6%)
Education$42.05 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,289 | 499 | 99.6% |
| Education | $42.05 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $2,181 | 93 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,600 | 74 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,414 | 87 | $0 (2022) |
| Lundbeck LLC | $943.57 | 39 | $0 (2024) |
| ABBVIE INC. | $870.79 | 40 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $832.10 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $622.43 | 23 | $0 (2024) |
| Allergan, Inc. | $595.94 | 26 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $584.50 | 26 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $271.09 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,862 | 68 | Otsuka America Pharmaceutical, Inc. ($404.52) |
| 2023 | $1,891 | 81 | Alkermes, Inc. ($436.68) |
| 2022 | $1,134 | 45 | ABBVIE INC. ($227.81) |
| 2021 | $965.42 | 44 | Alkermes, Inc. ($205.26) |
| 2020 | $710.04 | 32 | Alkermes, Inc. ($116.62) |
| 2019 | $1,466 | 69 | Sunovion Pharmaceuticals Inc. ($329.35) |
| 2018 | $1,784 | 88 | Sunovion Pharmaceuticals Inc. ($515.27) |
| 2017 | $1,518 | 82 | Sunovion Pharmaceuticals Inc. ($556.75) |
All Payment Transactions
509 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CNS | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $28.96 | General |
| 11/21/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: CNS | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $103.10 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $36.80 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/23/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: CNS | ||||||
| 10/15/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $30.08 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: ANTI-ANXIETY | ||||||
| 09/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $33.33 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 241 | 631 | $88,736 | $55,825 |
| 2022 | 4 | 151 | 254 | $36,494 | $24,693 |
| 2021 | 4 | 164 | 345 | $43,432 | $30,281 |
| 2020 | 6 | 234 | 776 | $138,552 | $75,874 |
Total Patients
790
Total Services
2,006
Medicare Billing
$186,672
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 276 | $33,120 | $22,805 | 68.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 67 | 238 | $33,322 | $18,448 | 55.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 65 | 66 | $16,123 | $10,714 | 66.5% |
| 90847 | Family psychotherapy with patient, 50 minutes | Office | 2023 | 18 | 29 | $4,191 | $2,504 | 59.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 19 | 22 | $1,980 | $1,354 | 68.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 108 | $12,960 | $9,102 | 70.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 46 | 46 | $11,233 | $8,213 | 73.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 34 | 66 | $9,241 | $5,171 | 56.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 22 | 34 | $3,060 | $2,207 | 72.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 163 | $18,964 | $13,626 | 71.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 41 | 41 | $9,923 | $7,305 | 73.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 45 | 105 | $9,535 | $6,556 | 68.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 20 | 36 | $5,011 | $2,793 | 55.7% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 12 | 203 | $81,200 | $34,505 | 42.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 282 | $25,905 | $19,135 | 73.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 61 | 187 | $16,924 | $11,887 | 70.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 33 | 34 | $6,306 | $4,889 | 77.5% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 38 | 57 | $6,348 | $4,327 | 68.2% |
| 90847 | Family psychotherapy including patient, 50 minutes | Office | 2020 | 12 | 13 | $1,868 | $1,130 | 60.5% |
About Dr. Felix Dron, M.D
Dr. Felix Dron, M.D is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518986561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Felix Dron, M.D has received a total of $11,331 in payments from pharmaceutical and medical device companies, with $1,862 received in 2024. These payments were reported across 509 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($11,289).
As a Medicare-enrolled provider, Dron has provided services to 790 Medicare beneficiaries, totaling 2,006 services with total Medicare billing of $186,672. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Brooklyn, NY
- Active Since 07/19/2006
- Last Updated 03/28/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1518986561
Products in Payments
- VRAYLAR (Drug) $1,417
- LATUDA (Drug) $1,414
- REXULTI (Drug) $1,360
- ARISTADA (Drug) $1,323
- INGREZZA (Drug) $832.10
- ABILIFY MAINTENA (Drug) $683.83
- Aristada 441 mg (Drug) $653.75
- INVEGA SUSTENNA (Drug) $465.06
- AUSTEDO (Drug) $385.96
- ABILIFY ASIMTUFII (Drug) $329.41
- FANAPT (Drug) $233.00
- Auvelity (Drug) $231.06
- TRINTELLIX (Drug) $209.93
- LYBALVI (Drug) $179.63
- CAPLYTA (Drug) $179.31
- BRINTELLIX (Drug) $170.48
- SPRAVATO (Drug) $152.82
- Trintellix (Drug) $151.26
- Austedo XR (Drug) $117.22
- LOREEV XR (Drug) $104.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Mark Owens, Do, DO
Psychiatry — Payments: $502,442
Psychiatry $502,442
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Louis Belzie, Md, Phd, MD, PHD
Psychiatry — Payments: $178,082
Psychiatry $178,082
Alexander Pinkusovich, Md, MD
Psychiatry — Payments: $111,246
Psychiatry $111,246
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833